MENU
+Compare
NKTX
Stock ticker: NASDAQ
AS OF
Oct 14 closing price
Price
$2.39
Change
+$0.13 (+5.75%)
Capitalization
170.46M

NKTX Nkarta Forecast, Technical & Fundamental Analysis

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NKTX with price predictions
Oct 08, 2025

NKTX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NKTX turned positive on September 26, 2025. Looking at past instances where NKTX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on NKTX as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for NKTX moved above the 200-day moving average on September 09, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTX advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where NKTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

NKTX moved below its 50-day moving average on October 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NKTX crossed bearishly below the 50-day moving average on September 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NKTX broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NKTX entered a downward trend on September 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.477) is normal, around the industry mean (23.456). P/E Ratio (0.000) is within average values for comparable stocks, (54.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.164). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.799).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NKTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NKTX is expected to report earnings to fall 1.84% to -30 cents per share on November 05

Nkarta NKTX Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.02
The last earnings report on August 12 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 1.14M shares outstanding, the current market capitalization sits at 170.46M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFVF46.50N/A
N/A
Alfa-Laval AB
ICHBF9.92N/A
N/A
Industrias CH
ZLDAF0.21N/A
N/A
Zelira Therapeutics Ltd.
NPACF15.57N/A
N/A
Quadient SA
ARRXF0.20-0.03
-13.04%
Archer Materials Ltd.

NKTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+4.63%
BEAM - NKTX
50%
Loosely correlated
-3.53%
SYRE - NKTX
47%
Loosely correlated
-1.18%
FATE - NKTX
47%
Loosely correlated
-14.98%
CRBU - NKTX
47%
Loosely correlated
-4.42%
DNLI - NKTX
45%
Loosely correlated
-2.54%
More